Bank of America Corp DE Grows Stock Holdings in SI-BONE, Inc. (NASDAQ:SIBN)

Bank of America Corp DE lifted its position in shares of SI-BONE, Inc. (NASDAQ:SIBN - Free Report) by 25.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 138,915 shares of the company's stock after purchasing an additional 28,288 shares during the period. Bank of America Corp DE owned 0.33% of SI-BONE worth $1,948,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the company. Mercer Global Advisors Inc. ADV bought a new position in shares of SI-BONE during the fourth quarter valued at about $210,000. Schonfeld Strategic Advisors LLC bought a new position in shares of SI-BONE during the fourth quarter valued at about $426,000. Northern Trust Corp lifted its position in shares of SI-BONE by 6.3% during the fourth quarter. Northern Trust Corp now owns 409,122 shares of the company's stock valued at $5,736,000 after purchasing an additional 24,214 shares in the last quarter. Aquatic Capital Management LLC lifted its position in shares of SI-BONE by 83.7% during the fourth quarter. Aquatic Capital Management LLC now owns 12,126 shares of the company's stock valued at $170,000 after purchasing an additional 5,526 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of SI-BONE by 11.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 31,742 shares of the company's stock valued at $446,000 after purchasing an additional 3,318 shares in the last quarter. 98.11% of the stock is owned by institutional investors.

SI-BONE Trading Up 3.1%

Shares of NASDAQ:SIBN traded up $0.57 on Thursday, hitting $19.06. The company had a trading volume of 1,057,390 shares, compared to its average volume of 380,941. The firm's 50-day simple moving average is $15.90 and its two-hundred day simple moving average is $15.42. SI-BONE, Inc. has a 1 year low of $11.70 and a 1 year high of $20.05. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $812.24 million, a price-to-earnings ratio of -20.72 and a beta of 0.82.

SI-BONE (NASDAQ:SIBN - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported ($0.15) EPS for the quarter, topping the consensus estimate of ($0.24) by $0.09. The firm had revenue of $47.29 million during the quarter, compared to analysts' expectations of $45.13 million. SI-BONE had a negative net margin of 23.82% and a negative return on equity of 22.51%. Equities analysts anticipate that SI-BONE, Inc. will post -0.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

SIBN has been the topic of several research reports. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $25.00 price objective on shares of SI-BONE in a research report on Tuesday, May 6th. Needham & Company LLC reissued a "buy" rating and issued a $24.00 price target on shares of SI-BONE in a research report on Tuesday, May 6th. Finally, Truist Financial boosted their price objective on shares of SI-BONE from $20.00 to $22.00 and gave the company a "buy" rating in a research note on Tuesday, May 6th.

Insider Activity

In other news, CFO Anshul Maheshwari sold 4,937 shares of SI-BONE stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $17.00, for a total transaction of $83,929.00. Following the sale, the chief financial officer now owns 265,356 shares in the company, valued at $4,511,052. This trade represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Michael A. Pisetsky sold 3,128 shares of the business's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $14.14, for a total transaction of $44,229.92. Following the completion of the sale, the senior vice president now owns 244,878 shares in the company, valued at $3,462,574.92. This represents a 1.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 92,565 shares of company stock valued at $1,669,871 in the last 90 days. 4.00% of the stock is currently owned by insiders.

SI-BONE Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.